This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Dofetilide, UK-68,798, UK-68798
Description: Dofetilide is a class III antiarrhythmic agent (see below). Specifically, it works by selectively blocking the rapid component of the delayed rectifier outward potassium current (IKr). This causes increase in the duration of the electrical impulse (action potential), primarily through an increase in the time tissue is refractory to a new impulse.
The Vaughan Williams Classification is as follows: I (blocks sodium channel; subclasses based on their effect on action potential duration), II (blocks beta-adrenergic receptors), III (blocks potassium efflux), IV (blocks L-type calcium channels, affecting conduction through the AV node between the upper and lower chambers of the heart), V (other).
Pink Sheet Tikosyn manufacturing issue resolved
Pink Sheet Tikosyn shortage over
Additional information available to subscribers only: